Solutions

COVID-19 Solution Digital Pathology CDMO BY GBC

GB SARS-CoV-2 Real-Time RT-PCR (E/ORF1ab)

An in vitro nucleic acid amplification test (NAT) for the qualitative detection of 2019 Novel Coronavirus (SARS-CoV-2) in respiratory tract specimens (i.e., nasopharyngeal/oropharyngeal swab or sputum specimens), serum or plasma

USEFUL RESOURCES

Add to List

> SPECIFICATION > FEATURE > ORDERING INFORMATION

SPECIFICATION

Number of tests	100
Targets	E gene and ORF1ab (RdRp) region of SARS-CoV-2 (COVID-19)
Internal Control	Pseudoviruses
Extraction Platform (compatible)	Magnetic beads / Column technology
Sample type	Respiratory specimens (i.e., nasopharyngeal/oropharyngeal swabs, nasal swabs and mid-turbinate swabs specimens)
PCR Instrument (compatible)	GB RealQuant® AIO, ABI 7500, Qiagen, Roche, Thermo, BioRad
Sensitivity (LoD)	100 copies/mL
Certification	TFDA / CE

FEATURE

Internal Controls are implemented to ensure quality of the experiement in whole process
Primer and probe designed for covering 3 target genes, including E, ORF1ab (RdRp), and IC.
Compatible with ready-to-use GB RealQuant® AIO as well as ABI (Thermo), BioRad, Roche, Qiagen extraction and PCR systems

ORDERING INFORMATION

Catalogue No.	Product
4PCO052E	GB SARS-CoV-2 Real-Time RT-PCR - 100T